Humana Inc. $HUM Stock Sold by Sivik Global Healthcare LLC

Sivik Global Healthcare LLC decreased its position in shares of Humana Inc. (NYSE:HUM) by 11.5% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 17,700 shares of the insurance provider’s stock after selling 2,300 shares during the period. Humana comprises about 4.2% of Sivik Global Healthcare LLC’s investment portfolio, making the stock its 2nd largest holding. Sivik Global Healthcare LLC’s holdings in Humana were worth $6,754,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. Johnson Financial Group Inc. bought a new position in Humana in the 2nd quarter valued at $26,000. Trust Co. of Vermont bought a new stake in Humana during the 2nd quarter worth about $28,000. Reflection Asset Management bought a new stake in Humana during the 4th quarter worth about $29,000. Bogart Wealth LLC grew its holdings in Humana by 192.0% during the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock worth $29,000 after acquiring an additional 48 shares during the last quarter. Finally, MidFirst Bank acquired a new stake in Humana in the 2nd quarter valued at about $35,000. Institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. Leerink Partners raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $513.00 target price for the company in a research note on Thursday, July 30th. Morgan Stanley raised shares of Humana from an “underweight” rating to an “overweight” rating in a research note on Friday. UBS Group increased their price target on shares of Humana from $405.00 to $495.00 and gave the company a “neutral” rating in a research note on Monday. Piper Sandler raised shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 price target for the company in a report on Thursday, July 30th. Finally, Cantor Fitzgerald upgraded shares of Humana from a “neutral” rating to an “overweight” rating and boosted their price objective for the stock from $300.00 to $460.00 in a research report on Wednesday, October 7th. Twenty-one research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Humana presently has a consensus rating of “Moderate Buy” and an average price target of $453.30.

Humana Trading Down 1.8%

HUM stock traded down $7.81 during midday trading on Tuesday, reaching $425.69. The stock had a trading volume of 1,170,547 shares, compared to its average volume of 1,664,688. The business has a fifty day simple moving average of $389.75 and a two-hundred day simple moving average of $336.54. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The firm has a market cap of $51.12 billion, a price-to-earnings ratio of 40.21, a PEG ratio of 2.67 and a beta of 0.74. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $456.50.

Humana (NYSE:HUM) last released its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. During the same period in the prior year, the company posted $6.27 EPS. The company’s revenue was up 26.2% compared to the same quarter last year. As a group, research analysts expect that Humana Inc. will post 9.00 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 27th. Investors of record on Friday, October 30th will be paid a dividend of $0.8850 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, October 30th. Humana’s payout ratio is 33.49%.

Key Stories Impacting Humana

Here are the key news stories impacting Humana this week:

• Positive Sentiment: BlackRock joint venture strengthens CenterWell strategy: Humana announced a new venture with funds managed by BlackRock to operate nearly 150 CenterWell Senior Primary Care clinics. BlackRock will hold a majority stake, while CenterWell will retain a minority interest, potentially providing Humana with additional capital and an asset-light operating structure. Humana Announces New Strategic Joint Venture with BlackRock
• Positive Sentiment: Analysts raised their valuation outlook: Mizuho increased its price target to $495 from $468 and maintained an outperform rating. Raymond James also upgraded Humana to outperform with a $520 target, supporting the bullish case for a recovery in Medicare Advantage profitability.
• Positive Sentiment: Medicare Advantage quality ratings improved: Humana said 95% of its members are enrolled in plans rated four stars or better for 2027. Higher ratings could support future quality bonuses, including potentially larger 2028 payments, and improve the competitiveness of Humana’s plan offerings. Humana Hits 95% Four-Star Coverage
• Positive Sentiment: Sector sentiment improved: UnitedHealth’s earnings beat and raised outlook lifted several managed-care stocks, including Humana, suggesting investors may be responding favorably to improving industry fundamentals.
• Neutral Sentiment: Unusual call-option activity: Traders purchased 8,702 Humana call options, 43% above average daily volume. This indicates increased speculative interest but does not guarantee sustained buying in the shares.
• Neutral Sentiment: Next earnings date set: Humana will report third-quarter 2026 results on November 6. The approaching release may encourage caution as investors await updated medical-cost trends and full-year guidance. Humana to Release Third Quarter 2026 Results
• Negative Sentiment: Valuation and execution concerns remain: After a substantial recent advance, investors may be taking profits and demanding evidence that improved Medicare Advantage ratings and the CenterWell venture will translate into stronger earnings. The company’s relatively elevated valuation increases sensitivity to any disappointing guidance or medical-cost developments.

Humana Company Profile

Humana Inc is a health and well-being company headquartered in Louisville, Kentucky. Founded in 1961, the company began as a nursing home operator before expanding into hospitals and health insurance. Today, Humana primarily provides health insurance products and healthcare services for older adults, individuals, military families and other members in the United States.

Humana’s insurance business offers Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid coverage in select markets.